Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temsirolimus Activity via PET in Renal Cell Cancer
NCT01246817Phase 2Unknown
- Sponsor
- Radboud University Medical Center
- Start
- Aug 2009
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temsirolimus in renal cell carcinoma (RCC), sponsored by Radboud University Medical Center. Status: unknown.
02
Drugs
temsirolimus
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT01246817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01246817.